Kedrion supports Italian product donation to Serbia
Three million Factor VIII units donated to Belgrade’s Clinical Center patients
Kedrion Biopharma signs agreement with European Hemophilia Consortium (EHC)
The agreement aims to improve patient access to coagulation disorders treatments in Europe
Kedrion Biopharma initiatives for World Hemophilia Day 2017
The goal is to provide wider access to plasma-derived therapies for coagulation disorders the world over
New company AO Kirov Plasma established in Russia
It’s a joint venture between Kedrion Biopharma, Nacimbio and Pharmastandard
Kedrion Biopharma supports the First Neuromuscular Diseases Day
The goal is to raise awareness of available diagnoses and treatments
TLS and Kedrion: creating added value for orphan drugs
IKOD plant in Siena committed to researching and developing effective therapies to treat particularly rare diseases
CSR: Kedrion Biopharma volunteers at Dynamo Academy Campus
First joint initiative between Kedrion and Dynamo Academy, the social entrerprise supporting Dynamo Camp
Kedrion Biopharma strengthens its presence in Russia
Memorandum of Understanding with Russian pharmaceutical companies for a joint plasma products manufacturing program
Hemophilia seen through children’s eyes: Kedrion teams up with LA Kelley
Three books of the series My First Factor Creation are now available for free download
Pharmaceutical digitization: how to improve patient care and engagement
Kedrion Biopharma Advisor Prof. Albert Farrugia lectures at “The Future of Science” Conference in Venice, Italy